Zynex, Inc. (NASDAQ:ZYXI) just released its latest full-year report and things are not looking great. It wasn't a great result overall - while revenue fell marginally short of analyst estimates at ...

Zynex, Inc. specializes in non-invasive pain management and patient monitoring, with promising advancements like the NiCO pulse oximeter targeting accurate readings for diverse skin tones. Despite ...

Zynex (NASDAQ:ZYXI) shares plunged in the premarket on Wednesday after the nerve stimulation product maker missed Street forecasts with its Q4 2024 financials, prompting RBC Capital Markets to ...

Royal Bank of Canada cut shares of Zynex (NASDAQ:ZYXI – Free Report) from an outperform rating to a sector perform rating in a research report sent to investors on Wednesday, Marketbeat.com reports.

Zynex (NASDAQ:ZYXI – Get Free Report) had its price objective lowered by equities researchers at HC Wainwright from $17.00 to $15.00 in a research note issued on Wednesday,Benzinga reports.

Law Offices of Howard G. Smith announces an investigation on behalf of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) investors concerning the Company’s possible violations of ...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) investors concerning the ...

Securities Fraud Investigation Into Zynex, Inc. (ZYXI) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz The Law Offices of Frank R. Cruz announces an ...

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Zynex, Inc. (“Zynex” or the “Company”) (NASDAQ: ZYXI) on behalf of investors concerning the ...

Zynex (ZYXI) delivered earnings and revenue surprises of -122.22% and 14.39%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock? Zynex ...